Clinical Trials Directory

Trials / Completed

CompletedNCT05645705

A Two-Week Study of Clinical Safety and Saliva Flow Quantification

Two-Week Clinical Safety and Saliva Flow Quantification

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
270 (actual)
Sponsor
Johnson & Johnson Consumer Inc. (J&JCI) · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the oral tissue tolerance (tissues within the mouth) for irritation caused by added ingredients in mouthwashes. This will be assessed based on oral tissue exams and adverse reactions.

Conditions

Interventions

TypeNameDescription
OTHERColgate Cavity Protection ToothpasteParticipants will use Colgate Cavity Protection Toothpaste for brushing teeth twice daily.
OTHERLISTERINE Cool Mint Antiseptic MouthwashParticipants will use 20 mL of LISTERINE Cool Mint Antiseptic Mouthwash for 30 seconds after brushing twice daily.
OTHERListerine Advanced Gum AlcoholParticipants will use 20 mL of Listerine Advanced Gum Alcohol Rinse for 30 seconds after brushing twice daily.
OTHERListerine Advanced Gum ZeroParticipants will use 20 mL of Listerine Advanced Gum Zero Rinse for 30 seconds after brushing twice daily.
OTHERLISTERINE ULTRACLEAN Tartar Control Antiseptic Mouthwash Cool MintParticipants will use 20 mL of LISTERINE ULTRACLEAN Tartar Control Antiseptic Mouthwash Cool Mint Rinse for 30 seconds after brushing twice daily.

Timeline

Start date
2022-11-28
Primary completion
2022-12-16
Completion
2022-12-16
First posted
2022-12-09
Last updated
2023-10-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05645705. Inclusion in this directory is not an endorsement.